ArticleJapanese journal of clinical oncology2024

Clinical response of pancreatic cancer bearing a germline BRCA2 p.I3169M fs*48 variant for platinum-based drug and PARP inhibitor.

Risa Akahira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.